Start: 09 Nov 2021, 18:30
End: 09 Nov 2021, 19:00
Multiple speakers: pre-recorded talks will be available to watch at any time during the day.
Abstract title: The challenges of informed decision-making about treatment and trial participation following cancer diagnosis: qualitative study involving adolescents and young adults with cancer and their caregivers
Abstract title: New clinical & biological insights at long-term follow up: TARGIT-A randomised trial of risk-adapted single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for breast cancer
Abstract title: Review of data quality following a transition to telephone follow up in phase III multicentre clinical trials as a result of the COVID-19 pandemic
Abstract title: Clinical outcomes by Charlson Comorbidity Index (CCI) score from a retrospective study of patients with advanced renal cell carcinoma (aRCC)
Abstract title: Are Circulating Frailty Biomarkers Useful In Patients Waiting for Early Clinical Trials?
Abstract title: CERES, a retrospective study of patients with advanced renal cell carcinoma who received cabozantinib as part of the UK Managed Access Program (MAP): baseline characteristics and clinical outcomes
Abstract title: Management of adverse events in patients with HER2+ metastatic breast cancer treated with tucatinib, trastuzumab, and capecitabine (HER2CLIMB)
Abstract title: Efficacy and safety of avelumab + axitinib (A+Ax) vs sunitinib (S) in elderly patients with advanced renal cell carcinoma (aRCC): extended follow-up results from JAVELIN Renal 101